Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
494
self-reported band not used
Founded
1990
36 years
Legal entities
None matched
Office countries
6
6 addresses
Funding rounds
1
Post IPO equity · Nov 2010 · US$ 219.1M
Company type
Public Company
self-reported
Description
Biosensors International develops, manufactures and markets pioneering interventional cardiology devices.
The BioMatrix™ DES family features Biolimus A9™ (BA9™), a highly lipophilic anti-restenotic drug designed for cardiovascular stent technologies patented by Biosensors, combined in a unique abluminal biodegradable polymer coating. BioMatrix Alpha™, the latest addition to the family, is a CoCr stent featuring an innovative hybrid design, thin struts and an advanced delivery system.
BioFreedom™ demonstrated superior safety and efficacy vs BMS in High Bleeding Risk patients in the landmark LEADERS FREE trial and features a selectively micro-structured abluminal surface allowing polymer & carrier free delivery of BA9™.
Recently Biosensors’ parent company made a significant investment into the rapidly growing field of structural heart disease intervention through the acquisition of the company New Valve Technology (NVT), the developers of the flagship product Allegra™ transfemoral TAVI system.
Together, Biosensors and NVT will leverage our their respective innovative expertise in Cardiovascular and Structural Heart technologies.
Our aim is to improve patients’ lives through pioneering medical technology that pushes the boundaries of innovation.
Through our high quality medical devices we impact the lives we touch and we are committed to continued investment in the development of pioneering medical technology, robust clinical data and engineering new medical devices that will further benefit your patients.
Specialties
All 6 specialties
- Cardiology medical device
- Structural Heart
- TAVI
- Stents
- Pioneering Technology
- Balloons
Locations
6
Countries with an office address6 addresses on record
Country footprint
Show as table · Offices in 6 countries
| Countries | 6 |
|---|---|
| Primary country | SG |
All codes: SG CH CN ID JP NL
Addresses
- SG36, Jalan Tukang; Singapore, 619266Primary
- CHRue de Lausanne 29; Morges, 1110
- JPNBF Hibiya Bldg. 1-1-7; Uchisaiwaicho, Chiyoda-ku; Tokyo, 100-0011
- NLArnoudstraat 8; Hillegom, 2182 DZ
- IDJalan Tanah Abang II No. 67; Jakarta Pusat , 10160
- CN68 Dalian Road,; Weihai, Shandong 264209
Grid intelligence Members
Funding
Rounds1
Round typePost IPO equity · secondary transaction
Amount (USD)219,100,000
Stage rank6
Investors named1
Since last round15 yr 2 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 1990 to 2026 |
| Post IPO equity · 14 Nov 2010 | US$ 219.1M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Biosensors International Group, Ltd?
The record holds 494 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
Where does Biosensors International Group, Ltd have offices?
Six addresses on record across 6 countries. Primary: 36, Jalan Tukang, Singapore 619266.
Has Biosensors International Group, Ltd raised funding?
One round. Latest 14 November 2010: post IPO equity, US$219,100,000, investor Hony Capital.
What does Biosensors International Group, Ltd list as its specialties?
Six tags on the brand's own list, among them Cardiology medical device, Structural Heart and TAVI.
Which companies are listed alongside Biosensors International Group, Ltd?
24 profiles list Biosensors International Group, Ltd as a peer — 98th percentile in Medical Device. It lists ten peers of its own. Standard Biosensor Indonesia lists it back.